New aspects of diagnosis and pharmacotherapy of eating disorders

International Journal of Psychiatry in Clinical Practice

Volumn 1, Issue 1, 1997, Pages 21-35

  Lennkh, Claudia ^a   De Zwaan, Martina ^a   Kasper, Siegfried ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Anorexia nervosa; Binge eating disorder; Bulimia nervosa; Diagnosis; Pharmacological treatment

Indexed keywords

EID: 0003003165     PISSN: 13651501     EISSN: None     Source Type: Journal    
DOI: 10.3109/13651509709069202     Document Type: Article

References (106)

1. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders (DSM IV). American Psychiatric Association, Washington DC.
2. Levine AS (1987) Centrally active peptides. Are they useful agents in the treatment of obesity? Ann NY Acad Sci 499: 297-304.
3. Jimerson DC, Lesem MD, Kaye WH, Brewerton TD (1992) Low serotonin and dopamine metabolite concentration in cerebro-spinal fluid from bulimic patients with frequent binge episodes. Arch Gen Psychiatry 49: 132-8.
4. Blundell JE, et al (1991) Pharmacological approaches to appetite suppression. Trends Pharmacol Sci 12: 147-57.
5. Leibowitz SF (1990) The role of serotonin in eating disorders. Drugs 39 (Suppl. 3): 33-48.
6. Fullerton DT, Getto CJ, Swift WA, Carlson IH (1985) Sugar, opioids and binge eatin. Brain Research Bulletin 14: 673-80.
7. Jimerson DC, Lesem MD, Kaye WH et al (1990) Eating disorders and depression: Is there a serotonin connection?. Biol Psychiatry 28: 443-54.
8. Sullivan PF (1995) Mortality in anorexia nervosa Am J Psychiatry 152: 1073-4.
9. Dally PJ, Sargant W (1960) A new treatment of anorexia nervosa. Br Med J 1: 1770-3.
10. Vandereycken W (1984) Neuroleptics in the short-term treatment of anorexia nervosa: a double-blind placebo-controlled study with sulpiride. Br J Psychiatry 144: 288-92.
11. Vandereycken W, Pierloot R (1982) Pimozide combined with behavior therapy in short term treatment of anorexia nervosa: a double-blind placebo-controlled cross-over study. Acta Psychiat Scand 66: 445-50.
12. Vigersky RA, Loriaux DL (1977) The effect of cyproheptadine in anorexia nervosa. In: Anorexia nervosa (ed RA Vigersky) 349-56. Raven Press, New York.
13. Goldberg SC, Halmi KA, Eckert ED et al (1979) Cyproheptadine in anorexia nervosa. Br J Psychiatry 346: 67-70.
14. Halmi KA, Eckert ED, LaDu TJ, Cohen J (1986) Anorexia nervosa. Treatment efficacy of cyproheptadine and amitriptyline. Arch Gen Psychiatry 43: 177-81.
15. Lacey JH, Crisp AH (1980) Hunger, food intake and weight: the impact of clomipramine on a refeeding anorexia nervosa population. Postgrad Med J 56 (Suppl. 1): 79-85.
16. Biederman J, Herzog DB, Rivinus TM et al (1985) Amitriptyline in the treatment of anorexia nervosa: a double-blind, placebo-controlled study J Clin Psychophannacol 5: 10-16.
17. Gwirtsman HE, Guze BH, Yager J, Gainsley B (1990) Fluoxetine treatment of anorexia nervosa: an open clinical trial. J Clin Psychiatry 51: 378-82.
18. Kaye WH, McConaha C, Nagata T et al (1996) Fluoxetine prevents relapse in a majority of patients with anorexia nervosa. Presented at the Eating Disorders Research Society Meeting, November 1996, Pittsburgh, PA.
19. Moore R, Mills IH (1981) Naloxone in the treatment of anorexia nervosa: Effect on weight gain and lipolysis. J R Soc Med 74: 129-31.
20. Gross H, Ebert MH, Faden VB (1981) A double-blind controlled trial of lithium carbonate in primary anorexia nervosa. J Clin Psychopharmacol 1: 376-81.
21. Moldovsky H, Jeunjewic N, Garfinkel PJ (1977) Preliminary report of metoclopramide in anorexia nervosa. In: Anorexia nervosa (ed RA Vigersky) 373 - 78. Raven Press, New York.
22. Craigen G, Kennedy SH, Garfinkel PE, Jeejeebhoy K (1987) Drugs that facilitate gastric emptening. In: The role of drug treatment for eating disorders. (ed PE Garfinkel, DM Garner) 161-76. Brunner & #38; Mazel, New York.
23. Stacher G, Abatzi-Wenzel TA, Wiesnagrotzki S et al (1993) Gastric emptening, body weight and symptoms in primary anorexia nervosa. Long term effects of cisapride. BrJ Psychiatry 162: 398-402.
24. Szmukler GI, Young GP, Miller G et al (1995) A controlled trial of cisapride in anorexia nervosa. Int J Eating Disord 17: 347-57.
25. Schlamp D, Schneider P, Krahl A et al (1995) Untersuchungen zur Knochendichte bei Anorexia nervosa mit Anmerkungen zur Prophylaxe und Therapie der Osteoporose. Z Kinder Jugendpsychiatr 22: 183-8.
26. Kreipe RE, Hicks DG, Rosnier RN, Puzas JE (1993) Preliminary findings on the effect of sexual hormones on bone metabolism in anorexia nervosa. J Adolescent Health 14: 319-24.
27. Siemers B, Chakmakjian Z, Gench B (1996) Bone density patterns in women with anorexia nervosa. Int J Eating Disord 19: 179-86.
28. Fichter MM (1993) Die medikamentöse Behandlung von Anorexia und Bulimia nervosa: Eine Übersicht. Nervenarzt 64: 21-35.
29. Hudson JI, Pope GP, Jonas JM (1987) A controlled study of lifetime prevalence of affective and other psychiatric disorders in bulimic outpatients. Am J Psychiatry 144: 1283-7.
30. Shisslak CM, Perse T, Crago M (1991) Coexistence of bulimia nervosa and mania: a literature review and case report. Compr Psychiatry 32: 181-4.
31. Gartner AF, Marcus RN, Halmi K, Loranger AW (1989) DSM-III-R personality disorders in patients with eating disorders AmJ Psychiatry 146: 1585-91.
32. Wonderlich SA, Mitchell JE (1991) Eating disorders and personality disorder In: Special problems in managing eating disorders. (ed J Yager et al.) American Psychiatric Press, Washington DC.
33. Favazza AR, De Rosear L, Conterio K (1989) Self-mutilation and eating disorders. Suicide Life Threat Behav 19: 352-61.
34. Pope HG Jr, Hudson JI, Jonas JM, Yurgelun-Todd D (1983) Bulimia treated with imipramine: a placebo-controlled, double-blind study. Am J Psychiatry 140: 554-8.
35. Hughes PL, Wells LA, Cunningham CJ, Ilstrup DM (1986) Treating bulimia with desipramine. Arch Gen Psychiatry 43: 182-6.
36. Home RL, Ferguson JM, Pope HG Jr (1988) Treatment of bulimia with bupropion: a multicenter controlled trial. J Clin Psychiatry 49: 262-6.
37. Walsh BT, Hadigan CM, Devlin MJ (1991) Long-term outcome of antidepressant treatment for bulimia nervosa. Am J Psychiatry 148: 1206-12.
38. Pyle RL, Mitchell JE, Eckert ED et al (1990) Maintenance treatment and 6 month outcome for bulimic patients who respond to initial treatment. Am J Psychiatry 147: 871-5.
39. Pope HG, Hudson JI, Jonas J, Yurgelun-Todd D (1985) Antidepressant treatment of bulimia: A two-year follow-up study. J Clin Psychopharmacol 5: 320-7.
40. Kasper S, Lepine JP, Mendlewicz J et al. (1994/95) Efficacy, safety and indications for tricyclic and newer antidepressants. Depression 2: 127-37.
41. Fluoxetine Bulimia Nervosa Collaborative Study Group (1992) Fluoxetine in the treatment of bulimia nervosa: A multicenter placebo-controlled double-blind trial. Arch Gen Psychiatry 49: 139-47.
42. Goldstein DJ, Wilson MG, Thompson VL et al (1995) Long-term fluoxetine treatment of bulimia nervosa. Br J Psychiatry 166: 660-6.
43. Ayuso-Gutierrez JL, Palazon M, Ayuso-Mateos JL (1994) Open trial of fluvoxamine in the treatment of bulimia nervosa. Int J Eating Disord 15: 245-9.
44. Mizes JS, Denise MS, Stephen R et al (1996) The efficacy of sertraline in bulimia nervosa patients. Presented at the Eating Disorders Research Society Meeting, November 1996; Pittsburgh, PA.
45. Geretsegger C, Greimel KV, Roed IS et al (1995) Ipsapirone in the treatment of bulimia nervosa: An open pilot study. Int J Eating Disord 17: 359-63.
46. Kim SW, Hartman BK, Faris PL et al (1996) Bulimia nervosa: Effects of ondansetron on binge/vomit frequencies. Presented at the 7th New York International Conference on Eating Disorders, April 1996.
47. Walsh BT, Gladis M, Roose SP, Stewart JW et al (1988) Phenelzine vs. placebo in 50 patients with bulimia nervosa. Arch Gen Psychiatry 45: 471-5.
48. Kennedy SH, Piran N, Warsh JJ et al (1988) A trial of isocarboxazid in the treatment of bulimia nervosa. J Clin Psychopharmacol 8: 391-6.
49. Kennedy SH, Goldbloom DS, Ralevski E et al (1993) Is there a role of selective monoamine oxidase inhibitor therapy in bulimia nervosa? A placebo-controlled trial of brofaromine. J Clin Psychopharmacol 3: 415-22.
50. Pope HG Jr, Keck PE Jr, McElroy SM, Hudson JI (1989) A placebo-controlled study of trazodone in bulimia nervosa. J Clin Psychopharmacol 9: 254-9.
51. Sabine EJ, Yonace A, Farrington AJ (1983) Bulimia nervosa: a placebo-controlled double-blind therapeutical trial of mianserin. Br J Clin Pharmacol 15 (Suppl. 2): 195S-202S.
52. Green RS, Rau JH (1974) Treatment of compulsive eating disturbances with anticonvulsant medication. Am J Psychiatry 131: 428-32.
53. Wermuth BM, Davis KL, Hollister LE, Stunkard AJ (1977) Phenytoin treatment of the binge eating syndrome Am J Psychiatry 148: 1206-12.
54. Greenway FL, Dahms WT, Bray DA (1977) Phenytoin as a treatment of obesity associated with compulsive eating. Curr Ther Res 21: 338-42.
55. Kaplan AS, Garfinkel PE, Darby PL, Garner DM (1983) Carbamazepine in the treatment of bulimia. Am J Psychiatry 140: 1225-6.
56. Mitchell JE, Laine DE, Morley JE, Levine AS (1986) Naloxone, but not CCK-8 may attenuate binge-eating behavior in patients with bulimia syndrome. Biol Psychiatry 21: 1399-1406.
57. Jonas JM, Gold MS (1986) Naltrexone reverses bulimic symptoms. Lancet i: 807.
58. Jonas JM, Gold MS (1988) The use of opiate antagonists in treating bulimia: A study of low-dose versus high-dose naltrexone. Psychiatry Res 24: 195-99.
59. JonasJM, Gold MS (1986) Treatment of antidepressant-resistant bulimia with naltrexone. Int J Psychiatry Med 16: 305-9.
60. Igoin-Apfelbaum L, Apfelbaum M (1987) Naltrexone and bulimic symptoms. Lancet i: 1087-8.
61. Mitchell JE, Christenson G, Jennings J et al (1989) A placebo-controlled, double-blind cross-over study of naltrexone in outpatients with normal weight bulimia. J Clin Psychopharmacol 9: 94-7.
62. Alger SA, Schwalberg MD, Bigaoutte JM et al (1991) Effects of a tricyclic antidepressant and opiate antagonist on binge-eating behavior in normal-weight bulimic and obese, binge-eating subjects. Am J Clin Nutr 53: 865-71.
63. Marrazzi MA, Bacon JP, Kinzie J, Luby ED (1995) Naltrexone use in the treatment of anorexia and bulimia nervosa. Int Clin Psychopharmacol 10: 163-72.
64. Bandecchi A (1996) Fluoxetine plus naltrexone in the treatment of bulimia nervosa. J Eur Coll Neuropsychopharmacol 6 (Suppl.3): S70-3.
65. de Zwaan M, Mitchell JE (1992) Opiate antagonists and eating behavior J Clin Pharmacol 32: 1060-72.
66. Hsu LKG, Clement L, Santhouse R, Ju ESY (1991) Treatment of bulimia nervosa with lithium carbonate: A controlled study. J Nerv Ment Dis 179: 351-5.
67. Fairburn CG, Norman PA, Welch SL et al (1995) A prospective study of outcome in bulimia nervosa and the long-term effects of three psychological treatments. Arch Gen Psychiatry 52: 304-12.
68. Mitchell JE, Pyle RL, Eckert ED et al (1990) A comparison study of antidepressants and structured intensive group psychotherapy in the treatment of bulimia nervosa. Arch Gen Psychiatry 47: 149-57.
69. Agras WS, Rossiter EM, Arnow B et al (1992) Pharmacological and cognitive-behavioral treatment for bulimia nervosa: A controlled comparison. Am J Psychiatry 149: 82-7.
70. Leitenberg H, Rosen JC, Wolf J et al. (1994) Comparison of cognitive-behaviour therapy and desipramine in the treatment of bulimia nervosa. Behav Res Ther 32: 37-45.
71. Fichter M, Leibl K, Rief W et al (1991) Fluoxetine versus placebo: a double-blind study with bulimic inpatients undergoing intensive psychotherapy. Pharmacopsychiatry 24: 1-7.
72. Devlin MJ, Walsh BT, Spitzer RL, Hasin D (1992) Is there another binge eating disorder? Int J Eating Disord 11: 333-40.
73. Spitzer RL, Devlin MJ, Walsh BT et al (1991) Binge eating disorder: To be or not to be in DSM IV. Int J Eating Disord 10: 627-9.
74. American Psychiatric Association (1993) Practice guidelines for eating disorders. Am J Psychiatry 150: 207-28.
75. Spitzer RL, Yanovski S, Wadden T et al (1993) Binge eating disorder: Its further validation in a multisite study. Int J Eating Disord 13: 137-53.
76. Hawkins RC, Clement PF (1980) Development and construct validation of a self-report measure of binge eating tendencies. Addict Behav 5: 219-26.
77. Marcus MD, Wing RR, Lamparski DM (1985) Binge eating and dietary restraint in obese patients. Addict Bchav 10: 163-8.
78. Kolotkin RL, Revis ES, Kirkeley BG, Janick L (1987) Binge eating in obesity: Associated MMPI characteristics. J Consult Clin Psychol 55: 872-6.
79. Yanovski SZ, Gormally JF, Leser MS et al (1994) Binge eating disorders affects outcome of comprehensive very low calorie diet treatment. Obesity Research 2: 205-12.
80. Mussell MP, Mitchell JE, de Zwaan M et al (1996) A comparison of women seeking weight loss treatment based on assessment of binge eating. Compr Psychiatry 20: 324-31.
81. Fichter MM, Quadflieg N, Brandi B (1993) Recurrent over-eating: an empirical comparison of binge eating disorder, bulimia nervosa, and obesity. Int J Eating Disord 14: 1-16.
82. Marcus MD, Smith D, Santelli R, Kaye W (1992) Characterization of eating disordered behavior in obese binge eaters. Int J Eating Disord 12: 249-55.
83. de Zwaan M, Nutzinger DO, Schönbeck G (1992) Binge eating in overweight females. Compr Psychiatry 33: 256-61.
84. Loro AD, Orleans CS (1981) Binge eating in obesity: Preliminary findings and guidelines for behavioral analysis and treatment. Addict Behav 6: 155-66.
85. Bruce B, Agras WS (1992) Binge eating in females: A population-based investigation. Int J Eating Disord 12: 365-73.
86. Telch CF, Agras WS, Rossiter EM (1988) Binge eating increases with increasing adiposity. Int J Eating Disord 7: 115-9.
87. Raymond N, Mussel M, Mitchell JE et al (1995) An age-matched comparison of subjects with binge eating disorder and bulimia nervosa. Int J Eating Disord 18: 135-43.
88. de Zwaan M, Mitchell JE, Seim HC et al (1994) Eating related and general psychopathology in obese females with binge eating disorder. Int J Eating Disorder 15: 43-52.
89. Specker S, de Zwaan M, Raymond N, Mitchell J (1994) Psychopathology in subgroups of obese women with and without binge eating disorder. Compr Psychiatry 35: 185-90.
90. Teich CF, Agras WS (1994) Obesity, binge eating and psychopathology: Are they related? Int J Eating Disord 15: 53-61.
91. Yanovski SZ, Nelson JE, Dubbert BK, Spitzer RL (1993) Association of binge eating disorder and psychiatric comorbid-ity in obese subjects. Am J Psychiatry 150: 1472-9.
92. Agras WS, Telch CF, Arnow B et al (1994) Weight loss, cognitive-behavioral, and desipramine treatment in binge eating disorder. An additive design. Behavior Therapy 25: 225-38.
93. Hudson JI, McElroy SL, Raymond NC et al (1996) Fluvoxamine in the treatment of binge eating disorder. Presented at the Symposium on OCD Spectrum Disorders, November 1996, Vienna.
94. Stunkard A, Berkowiu R, Taurikut C et al (1996) d-Fenfluramine treatment of binge eating disorder. Am J Psychiatry 153: 1455-59.
95. Marcus MD, Wing RR, Ewing L et al (1990) A double-blind, placebo-controlled trial of fluoxetine plus behavioral modification in the treatment of obese binge-eaters and non-binge eaters. Am J Psychiatry 147: 876-81.
96. Björvell H, Rôssner S (1992) A ten-year follow-up of weight change in severely obese subjects treated in a combined behavioral modification program. Int J Obesity 16: 1-8.
97. McCann UD, Agras WS (1990) Successful treatment of nonpurging bulimia nervosa with desipramine. Am J Psychiatry 47: 1509-13.
98. Prats M, Diez-Quevedo C, Avila C, Planell LS (1994) Paroxetine treatment for bulimia nervosa and binge eating disorder. Presented at the Sixth International Conference on Eating Disorders, April 1994, New York (Abstract 308).
99. Gardiner HM, Freeman CPL, Jesinger DK, Collins SA (1993) Fluvoxamine: an open pilot study in moderately obese female patients suffering from atypical eating disorders and episodes of bingeing. Int J Obesity 17: 301-5.
100. Walsh BT, Devlin MJ (1995) Pharmacotherapy of bulimia nervosa and binge eating disorder. Addict Behav 20: 757-64.
101. Jacobi C (1994) Pharmakotherapie und Verhaltenstherapie bei Anorexia und Bulimia nervosa. Verhaltenstherapie 4: 162-71.
102. Mitchell JE, Groat R (1984) A placebo-controlled, double-blind trial of amitriptyline in bulimia J Clin Psychopharmacol 4: 186-93.
103. Barlow S, Blouin J, Blouin A (1988) Treatment of bulimia with desipramine. A double-blind cross over study. Can J Psychiatry 330: 129-33.
104. Blouin AG, Blouin JH, Perez EL (1988) Treatment of bulimia with fenfluramine and desipramine. J Clin Psychophannacol 8: 261-69.
105. Agras WS, Doria B, Kirkley BG et al (1987) Imipramine in the treatment of bulimia: a double-blind controlled study. Int J Eating Disord 6: 29-38.
106. Freeman CPL, Davies F, Morris J et al (1997) A double-blind controlled trial of fluoxetine versus placebo for bulimia nervosa. Br J Psychiatry (in press).